SETBP1 and leukemia: SETBP1 mutations disrupt the degron motif of the protein, resulting in an impaired proteasome cleavage and subsequent SETBP1 protein accumulation, which further enhances the inhibitory effects of SET over PP2A and support leukemia cell proliferation [77,78].